Collage photo of Joe Y. Chang and Drew Moghanaki
May 15, 2025, 10:25
Drew Moghanaki: Is surgery still the optimal treatment for stage I non-small cell lung cancer?
Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X:
“It’s been nearly a decade since along with Joe Y Chang we celebrated the fortitude of thoracic surgeons who were the first physicians in history to provide a curative treatment for patients with lung cancer.”
Is surgery still the optimal treatment for stage I non-small cell lung cancer?
Authors: Drew Moghanaki, Joe Y. Chang
More posts featuring Drew Moghanaki.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 3, 2025, 12:31
Aug 3, 2025, 12:29
Aug 3, 2025, 12:13
Aug 3, 2025, 11:58
Aug 3, 2025, 11:55
Aug 3, 2025, 11:47